Interestingly, TrkA is also oncogenic and there is accumulating evidence for its overexpression and involvement in cancer progression [9,10,11,12,13,14], including in the form of TrkA fusion proteins as described in lung cancer [15]. The gene discussed is NTRK1; the disease is lung cancer.